Loading company…
Portuguese biotech developing molecular diagnostic assays for disease detection, mainly in oncology and infectious disease.
Founded in 2013 and headquartered in Cantanhede, Portugal, Magnomics develops molecular diagnostics tools with a focus on oncology and infectious diseases. Its assays are sold directly and through distributors to hospitals, laboratories and research institutions. The company raised EUR 0.25 mn in a Seed round in March 2017, with Portugal Ventures as the investor.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in